US EditionCovalon to Present at the 2025 Bloom Burton & Co. Healthcare Investor Conference on Tuesday, May 6, 2025
- Profound Medical Corp. Will present a business update at the Bloom Burton Healthcare Investor Conference on May 6, 2025, in Toronto.
- The presentation follows Profound’s development of incision-free therapies, including commercialization of TULSA-PRO and Sonalleve systems.
- TULSA-PRO uses MRI guidance and ultrasound to treat prostate diseases in a single, incisionless session while Sonalleve targets uterine fibroids and bone metastases non-invasively.
- TULSA-PRO holds CE mark, FDA clearance, and Health Canada approval, and the company noted it treats almost all prostate shapes without bleeding or hospital stays.
- This update may inform investors on Profound’s clinical progress and expanding treatment markets, potentially influencing its commercial trajectory.
11 Articles
11 Articles
Simcoe.com
Profound Medical to Participate in the 2025 Bloom Burton & Co. Healthcare Investor Conference
TORONTO, April 30, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today announced that management will present…
Covalon to Present at the 2025 Bloom Burton & Co. Healthcare Investor Conference on Tuesday, May 6, 2025
MISSISSAUGA, Ontario -- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that it will be presenting at the 2025 Bloom Burton & Co. Healthcare Investor Conference in Toronto on Tuesday, May 6, 2025 at 2:30 pm ET in Room 104 B at the Metro Toronto Convention Centre in Toronto. Brent Ashton, CEO of Covalon, will be hosting the presentation and answering quest…
Inside Ottawa Valley
BioSyent to Present at 2025 Bloom Burton & Co. Healthcare Investor Conference
MISSISSAUGA, Ontario, April 30, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it will be presenting at the upcoming 2025 Bloom Burton & Co. Healthcare Investor Conference. The conference will be held in…
Coverage Details
Bias Distribution
- 89% of the sources lean Left
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
